|The marine biodiscovery pipeline and ocean medicines of tomorrow|Jaspars, M.; De Pascale, D.; Andersen, J.H.; Reyes, F.; Crawford, A.D.; Ianora, A. (2016). The marine biodiscovery pipeline and ocean medicines of tomorrow. J. Mar. Biol. Ass. U.K. 96(01): 151-158. hdl.handle.net/10.1017/s0025315415002106
In: Journal of the Marine Biological Association of the United Kingdom. Cambridge University Press/Marine Biological Association of the United Kingdom: Cambridge. ISSN 0025-3154, more
Related to: Thorndyke, M.; McGowan, F.; Fleming, L.; Solo-Gabriele, H. (Ed.)
(2016). Oceans and Human Health. Journal of the Marine Biological Association of the United Kingdom
, 96(1). Cambridge University Press: Cambridge. 216 pp., more
drug discovery, ocean medicines, PharmaSea project
|Authors|| || Top |
- Jaspars, M.
- De Pascale, D.
- Andersen, J.H.
- Reyes, F.
- Crawford, A.D.
- Ianora, A.
Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties.